These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10963239)

  • 21. [Biochemical bases of the action of glucocorticoids on the heart].
    Seleznev IuM
    Probl Endokrinol (Mosk); 1982; 28(2):73-9. PubMed ID: 7043450
    [No Abstract]   [Full Text] [Related]  

  • 22. Non-genomic Effects of Glucocorticoids: An Updated View.
    Panettieri RA; Schaafsma D; Amrani Y; Koziol-White C; Ostrom R; Tliba O
    Trends Pharmacol Sci; 2019 Jan; 40(1):38-49. PubMed ID: 30497693
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Bronchial asthma and inflammatory dermatoses. Topical glucocorticoid treatment].
    Schäfer-Korting M; Korting HC
    Pharm Unserer Zeit; 2003; 32(4):306-13. PubMed ID: 12899068
    [No Abstract]   [Full Text] [Related]  

  • 24. Anti-inflammatory mechanisms of glucocorticoids.
    Barnes PJ
    Biochem Soc Trans; 1995 Nov; 23(4):940-5. PubMed ID: 8654871
    [No Abstract]   [Full Text] [Related]  

  • 25. Nitric oxide up-regulates the glucocorticoid receptor and blunts the inflammatory reaction in porcine endotoxin sepsis.
    Da J; Chen L; Hedenstierna G
    Crit Care Med; 2007 Jan; 35(1):26-32. PubMed ID: 17095945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo anti-inflammatory activity of the new glucocorticoid ciclesonide.
    Stoeck M; Riedel R; Hochhaus G; Häfner D; Masso JM; Schmidt B; Hatzelmann A; Marx D; Bundschuh DS
    J Pharmacol Exp Ther; 2004 Apr; 309(1):249-58. PubMed ID: 14718604
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Current issues of basic and clinical glucocorticoid research.
    Buttgereit F
    Clin Exp Rheumatol; 2003; 21(2):145-7. PubMed ID: 12747266
    [No Abstract]   [Full Text] [Related]  

  • 28. [Mechanisms of the anti-inflammatory action of glucocorticoids].
    Belovezhdov N
    Vutr Boles; 1985; 24(6):1-5. PubMed ID: 3913140
    [No Abstract]   [Full Text] [Related]  

  • 29. The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system. A critical evaluation of findings.
    Haller J; Mikics E; Makara GB
    Front Neuroendocrinol; 2008 May; 29(2):273-91. PubMed ID: 18054070
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Minimizing the side effects of glucocorticoid therapy.
    Baxter JD
    Adv Intern Med; 1990; 35():173-93. PubMed ID: 2405592
    [No Abstract]   [Full Text] [Related]  

  • 31. Topical corticosteroids: a review of properties and principles in therapeutic use.
    Chaffman MO
    Nurse Pract Forum; 1999 Jun; 10(2):95-105. PubMed ID: 10542586
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Topical corticoids for children: how to prescribe?].
    Stalder JF
    Rev Infirm; 1999 Jan; (45):48-51. PubMed ID: 10410071
    [No Abstract]   [Full Text] [Related]  

  • 33. In vitro and in vivo modulation of alpha- and beta-glucocorticoid-receptor mRNA in human bronchial epithelium.
    Korn SH; Wouters EF; Wesseling G; Arends JW; Thunnissen FB
    Am J Respir Crit Care Med; 1997 Mar; 155(3):1117-22. PubMed ID: 9116996
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimized glucocorticoid therapy: teaching old drugs new tricks.
    Strehl C; Buttgereit F
    Mol Cell Endocrinol; 2013 Nov; 380(1-2):32-40. PubMed ID: 23403055
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anti-inflammatory activity of glucocorticoids.
    de Waal RM
    Mol Biol Rep; 1994 Mar; 19(2):81-8. PubMed ID: 8072494
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical pharmacology of systemic corticosteroids.
    Melby JC
    Annu Rev Pharmacol Toxicol; 1977; 17():511-27. PubMed ID: 194533
    [No Abstract]   [Full Text] [Related]  

  • 37. Generic topical corticosteroids.
    Med Lett Drugs Ther; 1988 May; 30(765):49-50. PubMed ID: 3362092
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting inflammation using selective glucocorticoid receptor modulators.
    De Bosscher K; Haegeman G; Elewaut D
    Curr Opin Pharmacol; 2010 Aug; 10(4):497-504. PubMed ID: 20493772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of topical anti-inflammatory drugs on eosinophil survival primed by epithelial cells. Additive effect of glucocorticoids and nedocromil sodium.
    Mullol J; López E; Roca-Ferrer J; Xaubet A; Pujols L; Fernàndez-Morata JC; Fabra JM; Picado C
    Clin Exp Allergy; 1997 Dec; 27(12):1432-41. PubMed ID: 9433939
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel therapeutic agents targeting the glucocorticoid receptor for inflammation and cancer.
    Sommer P; Ray DW
    Curr Opin Investig Drugs; 2008 Oct; 9(10):1070-7. PubMed ID: 18821468
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.